I knew RP was extremely confident in our cancer ou
Post# of 148321
When I was previously looking it was because the stock didn’t move based on the preclinical results. I get it they are mice, but such compelling results I thought surely have a decent chance in humans. If these were the results of a larger company with analysts coverage some of them would likely give a fractional credit of success and thus impacting the share price a little. This will change once injection happens and we get interim results.
As always, thanks for the additional info and have a great weekend!